Total planned funding: $339,822,948
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $70,368,610 |
| South Africa | $46,080,853 |
| Asia Regional Program | $35,475,616 |
| Kenya | $28,888,903 |
| Mozambique | $23,289,394 |
| Zambia | $22,415,560 |
| Ethiopia | $15,911,301 |
| West Africa Region | $13,460,980 |
| Vietnam | $11,109,057 |
| Zimbabwe | $9,054,888 |
| Tanzania | $8,049,847 |
| Rwanda | $7,952,319 |
| Dominican Republic | $7,551,779 |
| Burundi | $6,708,625 |
| enumerations.Philippines | $6,341,584 |
| Guyana | $4,670,000 |
| Malawi | $3,988,600 |
| Lesotho | $3,392,229 |
| Botswana | $3,316,634 |
| Côte d'Ivoire | $3,036,882 |
| Uganda | $2,753,740 |
| Democratic Republic of the Congo | $2,290,015 |
| Eswatini | $1,960,500 |
| Haiti | $827,217 |
| Western Hemisphere Region | $709,018 |
| Namibia | $218,797 |
Organizational Types
| NGO | $339,822,948 |
Program Areas
| Treatment | $107,625,395 |
| Prevention | $86,193,312 |
| Care | $77,911,528 |
| Testing | $42,380,326 |
| Governance and Systems | $25,712,387 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $84,940,450 |
| HVCT: Testing: HIV Testing and Counseling | $42,380,326 |
| HKID: Care: Orphans and Vulnerable Children | $37,180,563 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $36,043,859 |
| HBHC: Care: Adult Care and Support | $31,230,867 |
| HTXD: Treatment: ARV Drugs | $20,922,484 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,669,946 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $17,058,953 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,850,673 |
| HVSI: Strategic Information | $9,795,316 |
| HLAB: Laboratory Infrastructure | $8,671,406 |
| OHSS: Health Systems Strengthening | $7,245,665 |
| HVTB: Care: TB/HIV | $7,186,597 |
| PDCS: Care: Pediatric Care and Support | $2,313,501 |
| PDTX: Treatment: Pediatric Treatment | $1,762,461 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $374,881 |
| HMIN: Biomedical Prevention: Injection Safety | $195,000 |
| HMBL: Biomedical Prevention: Blood Safety | $0 |